Publikationen

PubMed-Einträge

Prof. Dr. Guus Rimmelzwaan

Dr. Amare Aregay

Dr. Sharmistha Dam

Dr. Thomas Gerlach

Prajeeth K. Chittappen, PhD

Husni Elbahesh, PhD

Giulietta Saletti, PhD

 

weitere Publikationen in der AG Rimmelzwaan

Prof. Dr. Guus Rimmelzwaan

Westerhuis, B., Ten Hulscher, H., Jacobi, R., van Beek, J., Koopmans, M., Rimmelzwaan, G., Meijer, A., & van Binnendijk, R. (2020). Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus. Scientific Reports, 10: 3152. https://doi.org/10.1038/s41598-020-60048-9
Details anzeigen
Wilken, L., & Rimmelzwaan, G. F. (2020). Adaptive Immunity to dengue virus: Slippery slope or solid ground for rational vaccine design? Pathogens, 9(6:470). https://doi.org/10.3390/pathogens9060470
Details anzeigen
Wilken, L., Stanelle-Betram, S., Pinho dos Reis, V., Gerlach, T., Gabriel, G., & Rimmelzwaan, G. (2020). An influenza A virus–based vaccine candidate expressing Zika virus envelope protein domain III. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 13th Graduate School Days: 20/21 November 2020 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen
de Vries, R. D., Nieuwkoop, N. J., Krammer, F., Hu, B., & Rimmelzwaan, G. F. (2020). Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response. Virus Research: An International Journal of Molecular and Cellular Virology, 277: 197839. https://doi.org/10.1016/j.virusres.2019.197839
Details anzeigen
Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen
Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen
Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen
Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen
Jansen, J. M., Saletti, G., & Rimmelzwaan, G. F. (2019). Immune escape of the pandemic H1N1 Influenza virus from human T cell immunity. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen
Koel, B. F., Burke, D. F., van der Vliet, S., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., Smith, D. J., & Fouchier, R. A. M. (2019). Epistatic interactions can moderate the antigenic effect of substitutions in haemagglutinin of influenza H3N2 virus. Journal of General Virology, 100(5), 773–777. https://doi.org/10.1099/jgv.0.001263
Details anzeigen

Prajeeth K. Chittappen, PhD

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Husni Elhabesh, PhD

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen
Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen
Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen
Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
Details anzeigen
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen